Real-world experience with trifluridine/tipiracil on metastatic colorectal cancer in a third level hospital

被引：0
|
作者：
Rosero Rodriguez, D. [1 ]
Perez de Aguado, P. [2 ]
Chamorro Perez, J. [1 ]
Albarran Fernandez, V. [2 ]
Longo, F. [3 ]
Reguera Puertas, P. [4 ]
Delfrade, M. [4 ]
Fuentes Mateos, R. [2 ]
Guillen-Ponce, C.
Lopez Gomez, V. [2 ]
Rodriguez Garrote, M. [4 ]
Vaz, M. [1 ]
Villamayor Delgado, M. [1 ]
Fernandez Fradejas, J. [2 ]
Garrido, P. [2 ]
Gil, M. [1 ]
Pozas, J. [3 ]
Gemeno Lopez, E. [2 ]
Sotoca Rubio, P. [2 ]
Alia Navarro, V. [2 ]
Barrill Corpa, A. [4 ]
Ferreiro Monteagudo, R. [3 ]
机构：
[1] Inst Ramon & Cajal Invest Sanitaria, Hosp Univ Ramon & Cajal, Serv Oncol Med, Madrid, Spain
[2] Hosp Univ Ramon & Cajal, Madrid, Spain
[3] Inst Ramon & Cajal Invest Sanitaria, Hosp Univ Ramon & Cajal, Madrid, Spain
[4] Hosp Univ Ramon & Cajal, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.248
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-192
引用
收藏
页码：S84 / S84
页数：1
相关论文
共 50 条
  • [31] The safety of trifluridine and tipiracil for the treatment of metastatic colorectal cancer
    Martinez-Perez, Julia
    Carmen Riesco-Martinez, M.
    Garcia-Carbonero, Rocio
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (06) : 643 - 650
  • [32] Efficacy, safety and prognostic factors in patients with refractory metastatic colorectal cancer treated with trifluridine/tipiracil plus bevacizumab in a real-world setting
    Martinez-Lago, Nieves
    Calleja Chucla, Teresa
    Alonso De Castro, Beatriz
    Varela Ponte, Rafael
    Reboredo Rendo, Cristina
    Gomez-Randulfe Rodriguez, Martin Igor
    Silva Diaz, Sofia
    Grana Suarez, Begona
    de la Camara Gomez, Juan
    Busto Fernandez, Fernando
    Mateos Salvador, Maria
    Reboredo Lopez, Margarita
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [33] Comparison of the real-world adherence and compliance patterns with trifluridine/tipiracil (FTD/TPI) and regorafenib (REG) for the treatment of metastatic colorectal cancer (mCRC).
    Patel, Anuj K.
    Duh, Mei Sheng
    Barghout, Victoria
    Yenikomshian, Mihran Ara
    Xiao, Yongling
    Wynant, Willy
    Tabesh, Majid
    Fuchs, Charles S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [34] Treatment pattern and outcomes of trifluridine/tipiracil therapy for metastatic colorectal cancer in the real-world data from the JFMC50 study
    Kawakami, T.
    Yamazaki, K.
    Oki, E.
    Shimokawa, M.
    Takahashi, N.
    Yokota, M.
    Tokunaga, S.
    Esaki, T.
    Gamoh, M.
    Maeda, A.
    Tsuji, Y.
    Sakai, A.
    Hatanaka, K.
    Shimada, Y.
    Shiozawa, M.
    Komatsu, Y.
    Okuda, H.
    Ohue, M.
    Maehara, Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [35] Multi-institutional analysis of real-world activity and safety of trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer
    Arrichiello, G.
    Martinelli, E.
    Troiani, T.
    Incoronato, P.
    Nacca, V.
    Paragliola, F.
    Napolitano, R.
    Suarato, G.
    Nicastro, A.
    Perrone, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S295 - S295
  • [36] Effectiveness and safety of regorafenib and trifluridine/tipiracil in refractory metastatic colorectal cancer: A real-world multicenter retrospective study with focus on sequential treatment
    Signorelli, C.
    Schirripa, M.
    Chilelli, M. G.
    Calegari, M. A.
    Basso, M.
    Anghelone, A.
    Lucchetti, J.
    Minelli, A.
    Angotti, L.
    Morelli, C.
    Dell'Aquila, E.
    Cosimati, A.
    Gemma, D.
    Ribelli, M.
    Corsi, D. C.
    Arrivi, G.
    Zoratto, F.
    Morandi, M. G.
    Santamaria, F.
    Saltarelli, R.
    Ruggeri, E. M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S719 - S719
  • [37] Efficacy, safety and prognostic factors in patients with refractory metastatic colorectal cancer treated with trifluridine/tipiracil plus bevacizumab in a real-world setting
    Nieves Martínez-Lago
    Teresa Calleja Chucla
    Beatriz Alonso De Castro
    Rafael Varela Ponte
    Cristina Reboredo Rendo
    Martin Igor Gomez-Randulfe Rodriguez
    Sofia Silva Diaz
    Begoña Graña Suarez
    Juan de la Cámara Gomez
    Fernando Busto Fernández
    María Mateos Salvador
    Margarita Reboredo Lopez
    Scientific Reports, 12
  • [38] Trifluridine/Tipiracil in the Real-World Management of Metastatic Gastric and Gastroesophageal Junction Cancers in Canada
    Ding, Philip Q. Q.
    Dolley, Aastha
    Cheung, Winson Y. Y.
    CURRENT ONCOLOGY, 2023, 30 (01) : 130 - 144
  • [39] The REWRITE Study-REal-WoRld effectIveness of TrifluridinE/tipiracil in Patients with Previously Treated Metastatic Colorectal Cancer
    Marques, D.
    Costa, A. L.
    Mansinho, A.
    Quintela, A.
    Pratas, E.
    Brito-da-Silva, J.
    Cruz, J.
    Felix, J.
    Rodrigues, J.
    Mota, M.
    Teixeira, A. R.
    Damaso, S.
    Pinheiro, S.
    Andreozzi, V.
    Costa, L.
    Barros, A. G.
    CLINICAL ONCOLOGY, 2023, 35 (10) : 665 - 672
  • [40] Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
    Yoshiaki Fujimoto
    Ryota Nakanishi
    Mamoru Nukatsuka
    Kazuaki Matsuoka
    Koji Ando
    Takeshi Wakasa
    Hiroyuki Kitao
    Eiji Oki
    Yoshihiko Maehara
    Masaki Mori
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 1029 - 1038
12345